Envy Medical Launches Lumixyl® Trifecting™ Night Cream #EnvyMedical #Lumixyl

Multifunctional Anti-aging Treatment Makes Bare Skin Beautiful

envy skincare

Envy Medical, Inc., a leader in professional skincare products and services, announces the launch of Lumixyl® Trifecting™ Night Cream, an exceptional, targeted multifunctional anti-aging treatment that delivers powerful results in skin improvement. 
The next-generation night creams employ transdermal technology, combining three highly effective active ingredients into a single formulation to improve the appearance of fine lines and wrinkles, hyperpigmentation (sun spots, age spots, pregnancy mask) and blemishes. Unlike other products which often contain ingredients that don't effectively penetrate skin or work against each other, Lumixyl Trifecting Night Cream uses professional, results-driven ingredients in the purest and most penetrable forms to deliver transformative skin-refining results that could previously be achieved only with use of multiple products.  The introduction of Trifecting Night Cream represents a first in cross-category, multi-effect skin care products.
"The new transdermal technology found in Lumixyl Trifecting Night Cream allows us to deliver greater antiaging benefits from these ingredients," says Curtis A. Cluff, CEO of Envy Medical, Inc. "Consumers achieve results that are similar to using a prescription cream. With the Trifecting Night Creams, we've created an entirely new category of products that treat multi-functionally, rather than masking or covering problems without treating the skin. Our goal is to achieve skin so radiant that women can cut back on makeup and feel confident enough to sport bare skin."
Key ingredients include:
Decapeptide-12 – This patented Lumixyl peptide is the only peptide clinically shown to fade hyperpigmentation as effectively as prescription hydroquinone, and yet – unlike hydroquinone – is completely non-toxic to skin. 
PCX™ Technology – A patent-pending botanical complex that includes bakuchiol and bisabolol to improve skin's clarity, texture and reduce redness and irritation due to antioxidant, anti-inflammatory and anti-microbial properties.
Encapsulated Retinol – Retinol is a gold standard for addressing fine lines and wrinkles, photo damage, improving cellular turnover, and promoting healthy looking and acting skin. Lumixyl Trifecting Night Cream uses encapsulated retinol to ensure the right amount enters specific skin layers for maximum efficacy. A time-release mechanism reduces the risk of irritation, which enables higher levels of retinol to be absorbed.
"The Lumixyl Trifecting Night Creams are truly breakthrough professional-grade solutions that combine encapsulated retinol with two of Envy's proprietary technologies to tackle fine lines and wrinkles, dark spots and breakouts; arguably three of the biggest skin care concerns for adult women today," says Felipe Jimenez, Ph.D., Envy's Chief Scientific Officer. "It's like using three products in one, which will save our customers time and money." Continues Dr. Jimenez, "There is nothing on the market like it - nothing."
The latest addition to the Lumixyl family of products will be available in two strengths - Trifecting Night Cream 1.0 and Trifecting Night Cream 0.2. The more concentrated version contains 1% retinol, and is ideal for less sensitized, retinol-tolerant skin types. The 0.2 formula, containing 0.2% retinol, is best for new retinoid users, skin that's prone to irritation, or lighter skin types. In testing, subjects saw significant reduction in hyperpigmentation at 12 weeks.
Lumixyl Trifecting Night Cream will launch at AAD – March 20-24 in San Francisco - and will retail for $135. Visit the Envy Medical booth (#312) to be among the first to sample the product. 
ABOUT ENVY MEDICALEnvy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions.  The Company's lead products include SilkPeel®, a breakthrough device combining exfoliation with Advanced Dermalinfusion® Technology for deeper tissue delivery of active ingredients and better patient outcomes (www.silkpeel.com).  Envy is also the developer of the patent pending ClarityMD™ Acne Solution brand of acne treatment products (www.claritymdacne.com) and is the exclusive worldwide licensor of skin brightening peptides, including the Lumixyl® peptide, developed at Stanford University (www.lumixyl.com). More information can be found at www.envymedical.com.
SOURCE Envy Medical, Inc.
RELATED LINKShttp://www.envymedical.com